Having cancer is a known risk factor for thrombosis. A patient with cancer has a fourfold risk of developing venous thromboembolism.
The incidence of severe thrombotic events , which was relatively low was similar regardless of the treatment, and there were no grade 5 thrombotic events among patients treated with the combination of both targeted therapies.
The significant risk factors for VTEs identified in this study were being age 60 years or older, having a score of 1 on the ECOG Performance Status Scale, and response to treatment . At a press conference organized by the Institut Curie before the ASCO conference, Girard said,"There has been shown to be an increased risk of blood clots with the use of this combination of targeted therapies. Preventive measures should therefore also be put forward, such as adding anticoagulant medication. This is an important study for the further development of these therapies."
In a press release, the respiratory medicine specialist noted,"Institut Curie is particularly alert to the issue of the risk of thrombosis arising in cancer patients.
Girard has direct links with Amgen, AstraZeneca, AbbVie, BMS, Daiichi Sankyo, Ipsen, Janssen, Roche, Lilly, Medtronic, MSD, Novartis, OSE Pharma, Pfizer, Sanofi, and Sivan.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Which Alabama schools have students at risk of redoing third grade?According to results from Alabama’s 2023 reading test, 11,662 second graders, or 22% of students in the state, are not able to read grade level work. See how your school did here:
Read more »
Breakthrough for multiple sclerosis sufferers may involve helpful hormone: ‘Patients should remain optimistic’A recent study led by UCLA found that a pregnancy hormone called estriol could help repair damage in the cortex of the brain in multiple sclerosis patients. Here are details from researchers.
Read more »
USD/JPY approaches 142.00 amidst Fed Powell testimony and risk aversionThe USD/JPY exchanges hands at around the 142.00 handle on Wednesday, after hitting a low of 141.28, as the Federal Reserve (Fed) Chair Jerome Powell’
Read more »
Transplant surgeon sentenced to prison for failed stem cell treatmentsBreaking news: Surgeon Paolo Macchiarini, who was once hailed as a pioneer of stem cell medicine, was found guilty of gross assault against three of his patients today and sentenced to 2 years and 6 months in prison by an appeals court in Stockholm.
Read more »
HCA Kingwood's $28 million expansion underway as surgical patients increaseHCA Houston Healthcare Kingwood is embarking on a $28 million expansion of the...
Read more »